Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07602595 · ClinicalTrials.gov registry record

The BRIDGE Pain Study

A clinical trial, sponsored by Children's Hospital Medical Center, Cincinnati.

Recruiting
Registry status
600
Enrollment target

NCT07602595: Recruiting study, sponsored by Children's Hospital Medical Center, Cincinnati.

NCT07602595 is a clinical trial that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07602595 is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.

RECRUITING
Registry status
600 participants
Enrollment target

Study Summary

The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how the body feels pain, and they are also shaped by a person's biology, psychology, and social environment. Aim 1. We want to sort adolescents and young adults with long lasting muscle and bone pain into two different groups. To do this, we will look at participants' childhood medical histories, past treatments, when their pain started, the sex they were assigned at birth, what their pain feels like now, tests of how their body senses pain, and immune system markers found in their blood. We think we will find at least two different types of chronic pain groups, plus one group of patients who had a higher risk for pain (because of a rheumatic disease or past surgery) but never developed long term pain. Aim 2. We want to find out if certain patterns of inflammation in the body change how nerve cells react to pain. Aim 3: We want to understand how different biological, psychological, and social factors are connected to the chronic pain groups we identified. We think we will find certain mental, behavioral, and social risks-as well as protective factors-that help explain why some people develop long-lasting pain and others do not. We expect these factors to play different roles in each pain group, including the group that does not develop chronic pain.

Primary Outcome

CPM is defined by the change in pressure thresholds (increase) before and during cold immersion. Pressure thresholds will be measured using an algometer.

Interventions

  • OTHER Not applicable- observational study

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2026-08
Est. Completion 2029-08

What NCT07602595 shows while recruiting

NCT07602595 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Not applicable- observational study is the first listed.

NCT07602595 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07602595 about?

NCT07602595 is a clinical study titled "The BRIDGE Pain Study". The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how the body feels pain, and they are also shaped by a person's biology, psychology, and social environment. Aim 1. We want to...

What is the current status of trial NCT07602595?

This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2026-08. Estimated completion is 2029-08.

What interventions are being tested in trial NCT07602595?

The interventions under investigation include: Not applicable- observational study (OTHER).

Who is sponsoring clinical trial NCT07602595?

This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00004317 · 600 participants · Phase 4

    Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis

  • NCT00209235 · 600 participants · NA

    Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments

  • NCT01473784 · 600 participants · NA

    Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck

  • NCT01866371 · 600 participants

    High Resolution Retinal Imaging

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT07602595, the US trial registry maintained by the National Library of Medicine. NCT07602595 (mid enrollment · none site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.